Replies to post #82 on Nektar Therapeutics (NKTR)

[surf1944]

2. Nektar Therapeutics (NKTR): Biotechnology Industry. Market cap of $857.88M. Net institutional purchases over the current quarter at 15.6M shares, representing 15.01% of the company's 103.90M share float. RSI(14) at 35.89. The stock is trading 4.52% above its 52-week low. The stock is a short squeeze candidate, with a short float at 10.29% (equivalent to 11.52 days of average volume). The stock has lost 41.93% over the last year.

http://seekingalpha.com/article/278987-14-oversold-stocks-trading-near-lows-but-being-bought-up-by-the-smart-money?source=yahoo